Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.84 USD | +1.59% | +4.56% | +30.51% |
04:49pm | Piper Sandler Raiises Price Target on Organon to $24 From $22, Maintains Overweight Rating | MT |
Apr. 09 | Morgan Stanley Lifts Price Target on Organon to $18 From $17, Keeps Equalweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.51% | 4.77B | |
+25.89% | 661B | |
+26.77% | 566B | |
-6.68% | 352B | |
+20.41% | 332B | |
+2.62% | 283B | |
+13.40% | 231B | |
+4.75% | 200B | |
-9.33% | 195B | |
-5.27% | 145B |
- Stock Market
- Equities
- OGN Stock
- News Organon & Co.
- Organon Says Xaciato Vaginal Gel 2% Now Available in the US via Prescription to Treat Bacterial Vaginosis